Skip to main content
. 2020 Jun 23;14:1037–1047. doi: 10.2147/PPA.S232578

Table 1.

Characteristics of the Patients

Characteristics N=1237
Age (years) 48.9±13.4
Sex
 Male 217 (17.5%)
 Female 1020 (82.5%)
Occupation
 Persons in charge of party organizations, state organizations, mass organizations, social organizations, enterprises, and institutions 124 (10.0%)
 Professionals 109 (8.8%)
 Clerks 85 (6.9%)
 Service staff 148 (12.0%)
 Agricultural, forestry, animal husbandry, fisheries, and auxiliary personnel 183 (14.8%)
 Manufacturing and related personnel 39 (3.2%)
 Soldier 1 (0.1%)
 Others 548 (44.3%)
Education Level
 Junior high school or below 555 (44.9%)
 Senior high school 342 (27.6%)
 College 312 (25.2%)
 Master degree or above 28 (2.3%)
Duration of Rheumatoid Arthritis (Years)
 <2 385 (31.1%)
 2–5 358 (28.9%)
 6–10 218 (17.6%)
 >10 276 (22.3%)
Severity of the Disease Assessed by the Patient
 Severe 230 (18.6%)
 Moderate 543 (43.9%)
 Mild 425 (34.4%)
 Extremely mild 39 (3.2%)
DAS28-ESR 4.2±1.7
DAS28-CRP 3.7±1.6
PtGA 4.29±2.52
Current Medication
 csDMARDs 1037 (83.8%)
 Glucocorticoids 488 (39.5%)
 bDMARDs 202 (16.3%)
Communication with Physicians
 Full communication 818 (66.1%)
 Good communication, but a little hasty 247 (20.0%)
 Average communication level and can get the information 98 (7.9%)
 Less communication with physicians 60 (4.9%)
 Basically no communication 14 (1.1%)
Cost of Treatment for Rheumatoid Arthritis, Proportion of Household Income (%)
 <10 442 (35.7%)
 10–30 274 (22.2%)
 31–50 264 (21.3%)
 >50 257 (20.8%)
Satisfaction Towards General Diagnostic and Treatment Services
 Extremely satisfied 745 (60.2%)
 Very satisfied 287 (23.2%)
 Satisfied 109 (8.8%)
 Somewhat satisfied 79 (6.4%)
 Not quite satisfied 6 (0.5%)
 Dissatisfied 3 (0.2%)
 Extremely dissatisfied 8 (0.7%)

Note: Data are expressed as mean±standard deviation or n (%).

Abbreviations: bDMARDs, biological disease-modifying antirheumatic drugs; csDMARDS, conventional synthetic disease-modifying antirheumatic drugs; DAS28-ESR, disease activity score 28-erythrocyte sedimentation rate; DAS28-CRP, disease activity score 28-C-reactive protein; PtGA, patient global assessment of disease activity.